Life Science Institute, Inc.
|Head office||THE KAITEKI Building, 13‐4 Uchikanda 1‐chome, Chiyoda‐ku, Tokyo 101‐0047|
|Date of establishment||April 1, 2014|
|Paid-in capital||9,250 million yen|
|Line of business (consolidated)||Health and medical ICT, advanced medication, and drug development & manufacturing solutions|
|Sales revenue（Consolidated）||38.3 billion（FY2019）|
|Employees (Consolidated)||1,817(As of March 31, 2020)|